{"id":45351,"date":"2026-04-16T11:21:44","date_gmt":"2026-04-16T09:21:44","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=45351"},"modified":"2026-04-10T07:18:34","modified_gmt":"2026-04-10T05:18:34","slug":"ka-vara-tripeptids-ghk-ir-saistits-ar-novecosanas-izpeti-un-novecosanas-celiem","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/lv\/jak-tripeptyd-miedziowy-ghk-jest-powiazany-z-badaniami-nad-dlugowiecznoscia-i-szlakami-starzenia\/","title":{"rendered":"K\u0101 GHK vara tripept\u012bds ir saist\u012bts ar ilgm\u016b\u017e\u012bbas p\u0113t\u012bjumiem un noveco\u0161anas ce\u013ciem?"},"content":{"rendered":"

Vara tripept\u012bds GHK-K\u016b<\/mark> ir saist\u012bts ar p\u0113t\u012bjumiem par ilgm\u016b\u017e\u012bbu galvenok\u0101rt t\u0101 sp\u0113jas d\u0113\u013c ietekm\u0113t biolo\u0123iskos procesus, kas main\u0101s l\u012bdz ar vecumu, tostarp audu atjauno\u0161anu, iekaisuma kontroli, oksidat\u012bv\u0101 stresa samazin\u0101\u0161anu un g\u0113nu regul\u0113\u0161anu. Viena no ac\u012bmredzamaj\u0101m atzi\u0146\u0101m ir t\u0101, ka GHK dab\u012bgais l\u012bmenis laika gait\u0101 samazin\u0101s. Piem\u0113ram, t\u0101 koncentr\u0101cija samazin\u0101s no aptuveni 200 ng\/ml 20 gadu vecum\u0101 l\u012bdz aptuveni 80 ng\/ml 60 gadu vecum\u0101. \u0160is pak\u0101peniskais samazin\u0101jums liecina par iesp\u0113jamu saist\u012bbu starp zem\u0101ku \u0161\u012b pept\u012bda l\u012bmeni un ar vecumu saist\u012bt\u0101m organisma funkciju izmai\u0146\u0101m.<\/p>\n

Apl\u016bkojot tuv\u0101k GHK-Cu darb\u012bbas meh\u0101nismu, ir redzams, ka tas ietekm\u0113 galvenos biolo\u0123iskos procesus, kas saist\u012bti ar noveco\u0161anos. Tas atbalsta audu atjauno\u0161anos, palielinot aug\u0161anas faktoru l\u012bmeni, piem\u0113ram, VEGF un bFGF. \u0160ie faktori veicina jaunu asinsvadu veido\u0161anos un uzlabo sk\u0101bek\u013ca un uzturvielu pieg\u0101di audiem, \u012bpa\u0161i boj\u0101tiem vai novecojo\u0161iem. Turkl\u0101t GHK-Cu stimul\u0113 kolag\u0113na, elast\u012bna un glikozaminoglik\u0101nu ra\u017eo\u0161anu. \u0160\u012bs ir svar\u012bgas celtniec\u012bbas sast\u0101vda\u013cas, kas uztur \u0101du, saistaudos un asinsvadus lab\u0101 st\u0101vokl\u012b un nodro\u0161ina tiem elast\u012bbu. T\u0101 k\u0101 to ra\u017eo\u0161ana ar vecumu dab\u012bgi samazin\u0101s, to atbalst\u012b\u0161ana ir k\u013cuvusi par noz\u012bm\u012bgu ilgm\u016b\u017e\u012bbas p\u0113t\u012bjumu jomu.<\/p>\n

Vienlaikus GHK-Cu piem\u012bt antioksidanta un pretiekaisuma iedarb\u012bba. Tas pal\u012bdz ierobe\u017eot reakt\u012bvo sk\u0101bek\u013ca sugu (ROS) kl\u0101tb\u016btni, kas laika gait\u0101 var boj\u0101t \u0161\u016bnas. Tas ar\u012b atbalsta antioksidantu enz\u012bmus, piem\u0113ram, superoks\u012bda dismut\u0101zi (SOD), kas aizsarg\u0101 organismu no oksidat\u012bv\u0101 stresa. Papildus tam tas ietekm\u0113 iekaisuma sign\u0101lce\u013cus, piem\u0113ram, NF-\u03baB un p38 MAPK. T\u0101 k\u0101 hronisks, zems iekaisuma l\u012bmenis un oksidat\u012bvi boj\u0101jumi bie\u017ei ir saist\u012bti ar noveco\u0161anos, sp\u0113ja ietekm\u0113t \u0161\u012bs sign\u0101lce\u013cus padara GHK-Cu noz\u012bm\u012bgu vesel\u012bgas noveco\u0161an\u0101s p\u0113t\u012bjumos.<\/p>\n

N\u0101kam\u0101 svar\u012bg\u0101 joma ir g\u0113nu regul\u0101cija. G\u0113nu aktivit\u0101tes p\u0113t\u012bjumi liecina, ka GHK var ietekm\u0113t lielu skaitu cilv\u0113ka g\u0113nu, \u012bpa\u0161i tos, kas saist\u012bti ar atjauno\u0161anu, iekaisumu un visp\u0101r\u0113ju \u0161\u016bnu uztur\u0113\u0161anu. Ir nov\u0113rots, ka tas aktiviz\u0113 ar atjauno\u0161anos saist\u012btus g\u0113nus, vienlaikus samazinot ar iekaisumu un slim\u012bbu procesiem saist\u012btu g\u0113nu aktivit\u0101ti. Da\u017eos p\u0113t\u012bjumos GHK atbalsta ar\u012b ubikvit\u012bna-proteasomu sist\u0113mu. \u0160\u012b sist\u0113ma ir atbild\u012bga par boj\u0101tu vai nevajadz\u012bgu olbaltumvielu no\u0146em\u0161anu, kas ir svar\u012bgi vesel\u012bgu \u0161\u016bnu uztur\u0113\u0161anai. Tom\u0113r l\u012bdz ar vecumu t\u0101s darb\u012bba pal\u0113nin\u0101s, padarot to par svar\u012bgu noveco\u0161an\u0101s p\u0113t\u012bjumu jomu.<\/p>\n

Smadze\u0146a vesel\u012bbas kontekst\u0101 GHK ir par\u0101d\u012bjis interesantus efektus agr\u012bnos p\u0113t\u012bjumos. Novecojo\u0161\u0101m pel\u0113m tika nov\u0113rots iekaisuma samazin\u0101jums un ietekme uz epigen\u0113tiskajiem mar\u0137ieriem, piem\u0113ram, histona deacetil\u0101zes aktivit\u0101ti. \u0160\u012bs izmai\u0146as tika saist\u012btas ar\u012b ar m\u0101c\u012b\u0161an\u0101s sp\u0113ju uzlabo\u0161anos. Lai gan \u0161ie rezult\u0101ti liecina par iesp\u0113jamu saist\u012bbu ar kognit\u012bv\u0101s noveco\u0161anas procesiem, pieejamie pier\u0101d\u012bjumi joproj\u0101m ir s\u0101kotn\u0113ji un prasa turpm\u0101kus p\u0113t\u012bjumus, lai piln\u012bb\u0101 izprastu \u0161o lomu.<\/p>\n

GHK-Cu, ko izmanto p\u0113tnieciskos apst\u0101k\u013cos, ir pieejams t\u0101diem pieg\u0101d\u0101t\u0101jiem k\u0101 SemaxPolska. J\u0101saprot, ka sniegtie rezult\u0101ti ir balst\u012bti uz laboratorijas eksperimentiem, dz\u012bvnieku p\u0113t\u012bjumiem un g\u0113nu ekspresijas anal\u012bz\u0113m. Tie neapstiprina tie\u0161u ietekmi uz cilv\u0113ka dz\u012bves ilgumu vai kl\u012bniski pier\u0101d\u012btiem ar noveco\u0161anos saist\u012btiem efektiem.<\/p>\n

K\u0101das noveco\u0161an\u0101s paz\u012bmes tika p\u0113t\u012btas attiec\u012bb\u0101 uz vara tripept\u012bdu GHK?<\/strong><\/h2>\n
\n

GHK-Cu ir analiz\u0113ts saist\u012bb\u0101 ar vair\u0101k\u0101m labi zin\u0101m\u0101m noveco\u0161anas paz\u012bm\u0113m. Tie ietver procesus, piem\u0113ram, hronisku iekaisumu, oksidat\u012bvo stresu, \u0161\u016bnu noveco\u0161anos (senescenci), samazin\u0101tu sp\u0113ju izvad\u012bt boj\u0101tus prote\u012bnus, k\u0101 ar\u012b audu atjauno\u0161an\u0101s un re\u0123ener\u0101cijas sp\u0113ju samazin\u0101\u0161anos. Lai gan GHK-Cu ne vienm\u0113r ir ofici\u0101li iek\u013cauts klasiskaj\u0101 \u201enoveco\u0161anas paz\u012bmju\u201d model\u012b, t\u0101 darb\u012bbas nov\u0113rotie efekti atbilst daudz\u0101m galvenaj\u0101m biolo\u0123iskaj\u0101m izmai\u0146\u0101m, kas tiek p\u0113t\u012btas noveco\u0161anas kontekst\u0101.<\/p>\n

Viena no visbie\u017e\u0101k analiz\u0113taj\u0101m jom\u0101m ir hroniska iekaisums, ko bie\u017ei d\u0113v\u0113 par \u201eiekaisumu noveco\u0161anos\u201d (inflammaging). Ir pier\u0101d\u012bts, ka GHK-Cu pazemina proiekaisuma sign\u0101lu l\u012bmeni, piem\u0113ram, TNF-\u03b1 un IL-6. Tas ietekm\u0113 ar\u012b svar\u012bgus ce\u013cus, piem\u0113ram, NF-\u03baB un p38 MAPK, kas piedal\u0101s organisma iekaisuma reakcij\u0101. T\u0101 k\u0101 ilgsto\u0161s iekaisums ir saist\u012bts ar audu boj\u0101jumiem un ar vecumu saist\u012btu slim\u012bbu att\u012bst\u012bbu, \u0161is efekts tiek uzskat\u012bts par noz\u012bm\u012bgu noveco\u0161an\u0101s p\u0113t\u012bjumos.<\/p>\n

N\u0101kam\u0101 svar\u012bg\u0101 joma ir oksidat\u012bvais stress. GHK-Cu darbojas k\u0101 antioksidants, pal\u012bdzot neitraliz\u0113t reakt\u012bv\u0101s sk\u0101bek\u013ca formas, kas laika gait\u0101 var boj\u0101t \u0161\u016bnas. Tas ar\u012b atbalsta organisma dabisk\u0101s aizsardz\u012bbas sist\u0113mas, tostarp t\u0101dus enz\u012bmus k\u0101 superoks\u012bda dismut\u0101ze (SOD) un savienojumus, piem\u0113ram, glutationu. Turkl\u0101t tas var saist\u012bt toksiskus blakusproduktus, kas rodas lip\u012bdu oksid\u0101cijas laik\u0101, piem\u0113ram, akrole\u012bnu un 4-hidroksinonen\u0101lu. \u0160\u012bs vielas bie\u017ei saist\u0101s ar \u0161\u016bnu boj\u0101jumiem novecojo\u0161os audos.<\/p>\n

GHK-Cu tika p\u0113t\u012bts ar\u012b \u0161\u016bnu senescences kontekst\u0101. Tas ir process, kur\u0101 \u0161\u016bnas zaud\u0113 sp\u0113ju dal\u012bties un norm\u0101li funkcion\u0113t. P\u0113t\u012bjumos ar vec\u0101kiem fibroblastiem tika nov\u0113rots, ka GHK samazina ar senescenci saist\u012btus mar\u0137ierus, tostarp p21 un p53. Vienlaic\u012bgi tas atjaunoja \u0161\u016bnu kust\u012bgumu un aktivit\u0101ti. Tas ar\u012b veicin\u0101ja disfunkcion\u0101lu miofibroblastu elimin\u0101ciju apoptozes ce\u013c\u0101, kam ir noz\u012bme, ierobe\u017eojot audu fibrotiz\u0101ciju, kas bie\u017ei nov\u0113rota novecojo\u0161os audos.<\/p>\n

N\u0101kam\u0101 noveco\u0161an\u0101s paz\u012bme ir proteost\u0101zes zudums, kas ir organisma sp\u0113ju samazin\u0101\u0161an\u0101s nov\u0101kt boj\u0101tus vai nepareizi saloc\u012btus prote\u012bnus. P\u0113t\u012bjumi liecina, ka GHK var aktiviz\u0113t ubikvit\u012bna\u2013proteasomu sist\u0113mas elementus, kas ir atbild\u012bga par \u0161\u0101du prote\u012bnu nov\u0101k\u0161anu. \u0160\u012b sist\u0113ma ar vecumu v\u0101jin\u0101s un ir saist\u012bta ar t\u0101d\u0101m slim\u012bb\u0101m k\u0101 neirodegenerat\u012bvas slim\u012bbas.<\/p>\n

Papildus tam GHK-Cu \u0161\u0137iet, ka ietekm\u0113 cilmes \u0161\u016bnu aktivit\u0101ti un audu atjauno\u0161an\u0101s procesus. Tas ir saist\u012bts ar t\u0101du mar\u0137ieru k\u0101 p63 un PCNA ekspresijas palielin\u0101\u0161anos, kas saist\u012bti ar \u0161\u016bnu aug\u0161anu un sp\u0113ju atjaunoties. Tas atbalsta ar\u012b t\u0101dus procesus k\u0101 kolag\u0113na ra\u017eo\u0161ana, jaunu asinsvadu veido\u0161an\u0101s (angiogen\u0113ze) un \u0101rpus\u0161\u016bnu matricas p\u0101rveido\u0161ana. \u0160\u012bs funkcijas parasti paliek v\u0101j\u0101kas ar vecumu.<\/p>\n

Ir ar\u012b pier\u0101d\u012bjumi, ka GHK-Cu var ietekm\u0113t epi\u0123en\u0113tisko regul\u0101ciju. Tas ietver histonu deacetil\u0101zes aktivit\u0101tes izmai\u0146as un pla\u0161\u0101kus g\u0113nu ekspresijas mode\u013cus. \u0160\u0101das modifik\u0101cijas ir noz\u012bm\u012bgas, jo epi\u0123en\u0113tisk\u0101s izmai\u0146as tiek uzskat\u012btas par b\u016btisku noveco\u0161an\u0101s un ar vecumu saist\u012btu slim\u012bbu att\u012bst\u012bbas faktoru.<\/p>\n

J\u0101uzsver, ka sniegtie rezult\u0101ti ir no eksperiment\u0101liem un prekl\u012bniskiem p\u0113t\u012bjumiem. Tie tie\u0161i neapstiprina kl\u012bniskus efektus, kas saist\u012bti ar noveco\u0161anos vai slim\u012bbu profilaksi cilv\u0113kiem.<\/p>\n<\/section>\n

Atsauces<\/h4>\n
    \n
  • Dou Y, Lee A, Zhu L, Morton J, Ladiges W. GHK potenci\u0101ls k\u0101 pretnoveco\u0161an\u0101s pept\u012bds. Aging Pathobiol Ther. 2020. gada 27. marts; 2 (1): 58-61. doi: 10.31491 \/ apt.2020.03.014. PMID: 35083444; PMCID: PMC8789089. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8789089\/<\/span><\/li>\n
  • Pickart L, Margolina A. GHK-Cu pept\u012bda re\u0123enerat\u012bv\u0101s un aizsarg\u0101jo\u0161\u0101s darb\u012bbas jaun\u0101ko g\u0113nu datu gaism\u0101. Int J Mol Sci. 2018.\u00a0g. 7.\u00a0j\u016bl.;19(7):1987. doi: 10.3390\/ijms19071987. PMID: 29986520; PMCID: PMC6073405. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6073405\/<\/span><\/li>\n
  • Pickart, L., & Margolina, A. (2012). GHK pept\u012bda pretnoveco\u0161an\u0101s aktivit\u0101te \u2013 \u0101dai un ne tikai.\u00a0J Aging Res Clin Pract<\/i>,\u00a01<\/i>(1), 13-15. https:\/\/www.researchgate.net\/publication\/275893151_Anti-Aging_Activity_of_the_GHK_Peptide_-_The_skin_and_beyond<\/span><\/li>\n
  • Pickart L, Vasquez-Soltero JM, Margolina A. Cilv\u0113ka tripept\u012bds GHK-Cu noveco\u0161an\u0101s oksidat\u012bv\u0101 stresa un de\u0123enerat\u012bvo st\u0101vok\u013cu profilaks\u0113: implik\u0101cijas kognit\u012bvajai vesel\u012bbai. Oxid Med Cell Longev. 2012;2012:324832. doi: 10.1155\/2012\/324832. Epub 2012 May 10. PMID: 22666519; PMCID: PMC3359723. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3359723\/<\/span><\/li>\n
  • He Q, Mazzola J, Ladiges W. Dabiski sastopamais pept\u012bds GHK atgrie\u017e ar vecumu saist\u012btu fibrozi, modul\u0113jot miofibroblastu funkciju. Aging Pathobiol Ther. 2024. gada decembris; 6 (4): 186-190. doi: 10.31491 \/ apt.2024.12.158. Epub 2024. gada 28. decembris. PMID: 40823151; PMCID: PMC12352503. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12352503\/<\/span><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"

    Var\u0161aas vara tripept\u012bds GHK-Cu ir saist\u012bts ar ilgm\u016b\u017e\u012bbas p\u0113t\u012bjumiem galvenok\u0101rt t\u0101 sp\u0113jas d\u0113\u013c ietekm\u0113t biolo\u0123iskos procesus, kas main\u0101s l\u012bdz ar vecumu, piem\u0113ram,<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[93],"tags":[],"class_list":["post-45351","post","type-post","status-publish","format-standard","hentry","category-kategoria-ghk-cu","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts\/45351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/comments?post=45351"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts\/45351\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/media?parent=45351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/categories?post=45351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/tags?post=45351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}